The observations that PDGFB is largely immune-derived, sufficient to generate glioma in the absence of mutations64,65 and synergizes with IDH1R132H to accelerate disease progression raise the possibility that exogenous PDGFB may contribute to gliomagenesis. The gene discussed is PDGFB; the disease is central nervous system cancer.